SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-002193
Filing Date
2021-02-04
Accepted
2021-02-04 17:07:11
Documents
1
Period of Report
2021-02-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 13385
  Complete submission text file 0001567619-21-002193.txt   16541
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-39926 | Film No.: 21592084

Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022 212-739-6491
OrbiMed Capital GP VII LLC (Reporting) CIK: 0001760648 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39926 | Film No.: 21592085

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Issuer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022-4629
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022-4629 (212) 739-6400
OrbiMed Asia GP III, L.P. (Reporting) CIK: 0001841462 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39926 | Film No.: 21592086

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022-4629
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022-4629 (212) 739-6400
OrbiMed Advisors III Ltd (Reporting) CIK: 0001841537 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39926 | Film No.: 21592087